KBI Biopharma Inc. offer service "cGMP Mammalian Production"

KBI Biopharma delivers globally integrated cGMP mammalian production spanning early development through commercial supply, with facilities built around single-use bioprocessing for high-yield output of complex biologics. The company was among the first CDMOs to adopt 2,000L single-use cGMP manufacturing, and its scalable setup includes ten 2,000L single-use bioreactors, high-throughput systems such as AKTA Ready XL, 2500L single-use mixers, and 12m² TFF units, with a track record across mAbs, Fc-fusion proteins, and other recombinant biologics to support robust, compliant scale-up for clinical and commercial demand.